TREA

74593428 - "HIT"

Follow

Information

  • Trademark
  • 74593428
  • Serial Number
    74593428
  • Registration Number
    2108093
  • Filing Date
    November 01, 1994
    30 years ago
  • Registration Date
    October 28, 1997
    27 years ago
  • Transaction Date
    October 24, 2004
    20 years ago
  • Status Date
    July 31, 2004
    20 years ago
  • Published for Opposition Date
    August 05, 1997
    27 years ago
  • Location Date
    June 03, 2003
    21 years ago
  • Status Code
    710
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    MANDIR, FREDERICK M
  • Attorney Docket Number
    TM.1788
    Attorney Name
    IVOR M. HUGHES
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
1000
Mark Identification
"HIT"
Case File Statements
  • GS0051: pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of the following - cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sore, shingles; renal failure, cardiac insufficiency, hypertension, edema; infection, acne, monoucleosis; transplants; inflammation, elimination of tumor breakdown material (toxins and debris), decreasing side effects, relief of pain; detoxification; bronchodilation; vascular ischemia; HIV (AIDS); diabetes; post-menopause; prevention of topical infection; reduction of swelling; hypertension, cardiac insufficiency; prostaglandin synthesis inhibition; enhancement of oxygenation of tissue by perfusion fluid bathing of the tissue (for transplantation purposes); sub-retinal neovascularization and as an adjunct to the treatment of cancer to prevent metastasis; arthitis or pannus; cancer tumours; inhibiting angiogenesis; controlling angiogenesis; regressing angiogenesis; basal cell carcinoma; actinic keratoses; liver spots; squamous cell tumours; metastatic cancer of the breast to the skin; primary and metastatic melanoma of the skin; malignancies and/or tumour of the skin; genital warts (condyloma acuminata); cervical cancer; Human Papilloma Virus (HPV); psoriasis, corns on the feet; and hair loss on the heads of pregnant women; topical treatment of pain in the skin and or exposed tissue; clearing of atherosclerosis; prevention of arterial restenosis after balloon angioplasty; macrophage infilitration
  • GS0421: licensing the intellectual property technology regarding pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of medical conditions and disease in humans
Case File Event Statements
  • 7/31/2004 - 20 years ago
    14 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 10/28/1997 - 27 years ago
    13 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/5/1997 - 27 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/4/1997 - 27 years ago
    11 - NOTICE OF PUBLICATION Type: NPUB
  • 5/19/1997 - 27 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/2/1997 - 27 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/8/1997 - 28 years ago
    8 - FINAL REFUSAL MAILED Type: CNFR
  • 12/3/1996 - 28 years ago
    7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/6/1996 - 28 years ago
    6 - UNRESPONSIVE/DUPLICATE PAPER RECEIVED Type: UNPR
  • 6/4/1996 - 28 years ago
    5 - INQUIRY AS TO SUSPENSION MAILED Type: CNSI
  • 1/6/1996 - 29 years ago
    4 - LETTER OF SUSPENSION MAILED Type: CNSL
  • 10/6/1995 - 29 years ago
    3 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/8/1995 - 29 years ago
    2 - NON-FINAL ACTION MAILED Type: CNRT
  • 3/17/1995 - 29 years ago
    1 - ASSIGNED TO EXAMINER Type: DOCK